{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:28:23Z","timestamp":1791340103850,"version":"4.3.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/ng.3380","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T13:15:10Z","timestamp":1439817310000},"page":"1131-1140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies"],"prefix":"10.1038","volume":"47","author":[{"given":"Joseph","family":"Saliba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Saint-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Keren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique Della","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Secardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendoline","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Mahfoudhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Grosjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Droin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M'boyba","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Charrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberta","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Merlevede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-C\u00f4me","family":"Meniane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Delaunay-Darivon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Fuseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Solary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najet","family":"Debili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Raslova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Najman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bellann\u00e9-Chantelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Plo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"BFng3380_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","volume":"23","author":"WJ Song","year":"1999","unstructured":"Song, W.J. et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23, 166\u2013175 (1999).","journal-title":"Nat. Genet."},{"key":"BFng3380_CR2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","volume":"351","author":"ML Smith","year":"2004","unstructured":"Smith, M.L., Cavenagh, J.D., Lister, T.A. & Fitzgibbon, J. Mutation of CEBPA in familial acute myeloid leukemia. N. Engl. J. Med. 351, 2403\u20132407 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFng3380_CR3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn, C.N. et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012\u20131017 (2011).","journal-title":"Nat. Genet."},{"key":"BFng3380_CR4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","volume":"121","author":"M Pasquet","year":"2013","unstructured":"Pasquet, M. et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121, 822\u2013829 (2013).","journal-title":"Blood"},{"key":"BFng3380_CR5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","volume":"124","author":"D Bluteau","year":"2014","unstructured":"Bluteau, D. et al. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J. Clin. Invest. 124, 580\u2013591 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFng3380_CR6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2005-12-4852","volume":"108","author":"C Bellann\u00e9-Chantelot","year":"2006","unstructured":"Bellann\u00e9-Chantelot, C. et al. Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood 108, 346\u2013352 (2006).","journal-title":"Blood"},{"key":"BFng3380_CR7","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/blood-2009-01-197525","volume":"114","author":"C Saint-Martin","year":"2009","unstructured":"Saint-Martin, C. et al. Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms. Blood 114, 1628\u20131632 (2009).","journal-title":"Blood"},{"key":"BFng3380_CR8","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1200\/JCO.2012.47.8669","volume":"32","author":"O Yamada","year":"2014","unstructured":"Yamada, O. et al. Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone. J. Clin. Oncol. 32, e76\u2013e79 (2014).","journal-title":"J. Clin. Oncol."},{"key":"BFng3380_CR9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","volume":"41","author":"AV Jones","year":"2009","unstructured":"Jones, A.V. et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat. Genet. 41, 446\u2013449 (2009).","journal-title":"Nat. Genet."},{"key":"BFng3380_CR10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","volume":"41","author":"O Kilpivaara","year":"2009","unstructured":"Kilpivaara, O. et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms. Nat. Genet. 41, 455\u2013459 (2009).","journal-title":"Nat. Genet."},{"key":"BFng3380_CR11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","volume":"41","author":"D Olcaydu","year":"2009","unstructured":"Olcaydu, D. et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat. Genet. 41, 450\u2013454 (2009).","journal-title":"Nat. Genet."},{"key":"BFng3380_CR12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ajh.23842","volume":"89","author":"R J\u00e4ger","year":"2014","unstructured":"J\u00e4ger, R. et al. Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms. Am. J. Hematol. 89, 1107\u20131110 (2014).","journal-title":"Am. J. Hematol."},{"key":"BFng3380_CR13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/leu.2014.48","volume":"28","author":"A Oddsson","year":"2014","unstructured":"Oddsson, A. et al. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms. Leukemia 28, 1371\u20131374 (2014).","journal-title":"Leukemia"},{"key":"BFng3380_CR14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"BFng3380_CR15","doi-asserted-by":"crossref","first-page":"e74257","DOI":"10.1371\/journal.pone.0074257","volume":"8","author":"J Saliba","year":"2013","unstructured":"Saliba, J. et al. Heterozygous and homozygous JAK2V617F states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients. PLoS ONE 8, e74257 (2013).","journal-title":"PLoS ONE"},{"key":"BFng3380_CR16","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1182\/blood-2007-10-117622","volume":"111","author":"N Takayama","year":"2008","unstructured":"Takayama, N. et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111, 5298\u20135306 (2008).","journal-title":"Blood"},{"key":"BFng3380_CR17","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2008-09-178863","volume":"114","author":"O Klimchenko","year":"2009","unstructured":"Klimchenko, O. et al. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell\u2013derived primitive hematopoiesis. Blood 114, 1506\u20131517 (2009).","journal-title":"Blood"},{"key":"BFng3380_CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood-2004-04-1649","volume":"105","author":"MA Vodyanik","year":"2005","unstructured":"Vodyanik, M.A., Bork, J.A., Thomson, J.A. & Slukvin, I.I. Human embryonic stem cell\u2013derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105, 617\u2013626 (2005).","journal-title":"Blood"},{"key":"BFng3380_CR19","first-page":"1382","volume":"290","author":"JF Prchal","year":"1974","unstructured":"Prchal, J.F. & Axelrad, A.A. Letter: bone-marrow responses in polycythemia vera. N. Engl. J. Med. 290, 1382 (1974).","journal-title":"N. Engl. J. Med."},{"key":"BFng3380_CR20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James, C. et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434, 1144\u20131148 (2005).","journal-title":"Nature"},{"key":"BFng3380_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2040620713489144","volume":"4","author":"AV Jones","year":"2013","unstructured":"Jones, A.V. & Cross, N.C. Inherited predisposition to myeloproliferative neoplasms. Ther. Adv. Hematol. 4, 237\u2013253 (2013).","journal-title":"Ther. Adv. Hematol."},{"key":"BFng3380_CR22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.hoc.2012.07.005","volume":"26","author":"AS Harutyunyan","year":"2012","unstructured":"Harutyunyan, A.S. & Kralovics, R. Role of germline genetic factors in MPN pathogenesis. Hematol. Oncol. Clin. North Am. 26, 1037\u20131051 (2012).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"BFng3380_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fon.12.34","volume":"8","author":"AC Krepischi","year":"2012","unstructured":"Krepischi, A.C., Pearson, P.L. & Rosenberg, C. Germline copy number variations and cancer predisposition. Future Oncol. 8, 441\u2013450 (2012).","journal-title":"Future Oncol."},{"key":"BFng3380_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.gde.2010.03.005","volume":"20","author":"RP Kuiper","year":"2010","unstructured":"Kuiper, R.P., Ligtenberg, M.J., Hoogerbrugge, N. & Geurts van Kessel, A. Germline copy number variation and cancer risk. Curr. Opin. Genet. Dev. 20, 282\u2013289 (2010).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFng3380_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2011-01-331678","volume":"118","author":"T Klampfl","year":"2011","unstructured":"Klampfl, T. et al. Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Blood 118, 167\u2013176 (2011).","journal-title":"Blood"},{"key":"BFng3380_CR26","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1038\/bcj.2011.39","volume":"1","author":"KL Rice","year":"2011","unstructured":"Rice, K.L. et al. Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms. Blood Cancer J. 1, e40 (2011).","journal-title":"Blood Cancer J."},{"key":"BFng3380_CR27","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ajh.22166","volume":"86","author":"E Rumi","year":"2011","unstructured":"Rumi, E. et al. Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm. Am. J. Hematol. 86, 974\u2013979 (2011).","journal-title":"Am. J. Hematol."},{"key":"BFng3380_CR28","first-page":"365318","volume":"2010","author":"W Cui","year":"2010","unstructured":"Cui, W. et al. Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression. J. Biomed. Biotechnol. 2010, 365318 (2010).","journal-title":"J. Biomed. Biotechnol."},{"key":"BFng3380_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-4608(93)90146-D","volume":"66","author":"M Mancini","year":"1993","unstructured":"Mancini, M. et al. Trisomy 14 in hematologic diseases. Another non-random abnormality within myeloid proliferative disorders. Cancer Genet. Cytogenet. 66, 39\u201342 (1993).","journal-title":"Cancer Genet. Cytogenet."},{"key":"BFng3380_CR30","first-page":"117","volume":"4","author":"F Mertens","year":"1990","unstructured":"Mertens, F. et al. Trisomy 14 in atypical chronic myeloid leukemia. Leukemia 4, 117\u2013120 (1990).","journal-title":"Leukemia"},{"key":"BFng3380_CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2141.1997.1863003.x","volume":"98","author":"CL Toze","year":"1997","unstructured":"Toze, C.L., Barnett, M.J., Naiman, S.C. & Horsman, D.E. Trisomy 14 is a non-random karyotypic abnormality associated with myeloid malignancies. Br. J. Haematol. 98, 177\u2013185 (1997).","journal-title":"Br. J. Haematol."},{"key":"BFng3380_CR32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.leu.2404896","volume":"22","author":"C Bellanne-Chantelot","year":"2008","unstructured":"Bellanne-Chantelot, C., Jego, P., Lionne-Huyghe, P., Tulliez, M. & Najman, A. The JAK2V617F mutation may be present several years before the occurrence of overt myeloproliferative disorders. Leukemia 22, 450\u2013451 (2008).","journal-title":"Leukemia"},{"key":"BFng3380_CR33","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2014-01-550434","volume":"123","author":"E Rumi","year":"2014","unstructured":"Rumi, E. et al. CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis. Blood 123, 2416\u20132419 (2014).","journal-title":"Blood"},{"key":"BFng3380_CR34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMc1413718","volume":"372","author":"X Cabagnols","year":"2015","unstructured":"Cabagnols, X., Cayuela, J.M. & Vainchenker, W. A CALR mutation preceding BCR-ABL1 in an atypical myeloproliferative neoplasm. N. Engl. J. Med. 372, 688\u2013690 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFng3380_CR35","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau, F. et al. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360, 2289\u20132301 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFng3380_CR36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","volume":"70","author":"O Abdel-Wahab","year":"2010","unstructured":"Abdel-Wahab, O. et al. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res. 70, 447\u2013452 (2010).","journal-title":"Cancer Res."},{"key":"BFng3380_CR37","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg, P. et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 123, 2220\u20132228 (2014).","journal-title":"Blood"},{"key":"BFng3380_CR38","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ng.2759","volume":"45","author":"K Yoshida","year":"2013","unstructured":"Yoshida, K. et al. The landscape of somatic mutations in Down syndrome\u2013related myeloid disorders. Nat. Genet. 45, 1293\u20131299 (2013).","journal-title":"Nat. Genet."},{"key":"BFng3380_CR39","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1073\/pnas.1211175109","volume":"109","author":"ST Chou","year":"2012","unstructured":"Chou, S.T. et al. Trisomy 21\u2013associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 109, 17573\u201317578 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3380_CR40","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1073\/pnas.1215468109","volume":"109","author":"GA Maclean","year":"2012","unstructured":"Maclean, G.A. et al. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc. Natl. Acad. Sci. USA 109, 17567\u201317572 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3380_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","volume":"471","author":"A Gore","year":"2011","unstructured":"Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63\u201367 (2011).","journal-title":"Nature"},{"key":"BFng3380_CR42","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477\u20132487 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFng3380_CR43","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFng3380_CR44","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","volume":"10","author":"T McKerrell","year":"2015","unstructured":"McKerrell, T. et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 10, 1239\u20131245 (2015).","journal-title":"Cell Rep."},{"key":"BFng3380_CR45","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472\u20131478 (2014).","journal-title":"Nat. Med."},{"key":"BFng3380_CR46","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1084\/jem.20131371","volume":"211","author":"P Lundberg","year":"2014","unstructured":"Lundberg, P. et al. Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F. J. Exp. Med. 211, 2213\u20132230 (2014).","journal-title":"J. Exp. Med."},{"key":"BFng3380_CR47","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1242\/jcs.156034","volume":"127","author":"C Kishi-Itakura","year":"2014","unstructured":"Kishi-Itakura, C., Koyama-Honda, I., Itakura, E. & Mizushima, N. Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells. J. Cell Sci. 127, 4089\u20134102 (2014).","journal-title":"J. Cell Sci."},{"key":"BFng3380_CR48","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/path.2509","volume":"217","author":"MR Kang","year":"2009","unstructured":"Kang, M.R. et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J. Pathol. 217, 702\u2013706 (2009).","journal-title":"J. Pathol."},{"key":"BFng3380_CR49","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4161\/auto.7.9.15886","volume":"7","author":"M Mortensen","year":"2011","unstructured":"Mortensen, M., Watson, A.S. & Simon, A.K. Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation. Autophagy 7, 1069\u20131070 (2011).","journal-title":"Autophagy"},{"key":"BFng3380_CR50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature11895","volume":"494","author":"MR Warr","year":"2013","unstructured":"Warr, M.R. et al. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 494, 323\u2013327 (2013).","journal-title":"Nature"},{"key":"BFng3380_CR51","doi-asserted-by":"crossref","first-page":"11379","DOI":"10.1021\/bi061147r","volume":"45","author":"HY Chou","year":"2006","unstructured":"Chou, H.Y. et al. GSKIP is homologous to the Axin GSK3 (interaction domain and functions as a negative regulator of GSK3\u03b2. Biochemistry 45, 11379\u201311389 (2006).","journal-title":"Biochemistry"},{"key":"BFng3380_CR52","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/jcb.22362","volume":"108","author":"CC Lin","year":"2009","unstructured":"Lin, C.C. et al. GSKIP, an inhibitor of GSK3\u03b2, mediates the N-cadherin\/\u03b2-catenin pool in the differentiation of SH-SY5Y cells. J. Cell. Biochem. 108, 1325\u20131336 (2009).","journal-title":"J. Cell. Biochem."},{"key":"BFng3380_CR53","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1182\/blood-2007-09-111518","volume":"111","author":"D Li","year":"2008","unstructured":"Li, D., August, S. & Woulfe, D.S. GSK3\u03b2 is a negative regulator of platelet function and thrombosis. Blood 111, 3522\u20133530 (2008).","journal-title":"Blood"},{"key":"BFng3380_CR54","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.cellsig.2008.09.001","volume":"20","author":"M Soda","year":"2008","unstructured":"Soda, M., Willert, K., Kaushansky, K. & Geddis, A.E. Inhibition of GSK-3\u03b2 promotes survival and proliferation of megakaryocytic cells through a \u03b2-catenin\u2013independent pathway. Cell. Signal. 20, 2317\u20132323 (2008).","journal-title":"Cell. Signal."},{"key":"BFng3380_CR55","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1073\/pnas.0900189106","volume":"106","author":"AE Abrahamsson","year":"2009","unstructured":"Abrahamsson, A.E. et al. Glycogen synthase kinase 3\u03b2 missplicing contributes to leukemia stem cell generation. Proc. Natl. Acad. Sci. USA 106, 3925\u20133929 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3380_CR56","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. The Wnt\/\u03b2-catenin pathway is required for the development of leukemia stem cells in AML. Science 327, 1650\u20131653 (2010).","journal-title":"Science"},{"key":"BFng3380_CR57","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","volume":"110","author":"A Tefferi","year":"2007","unstructured":"Tefferi, A. et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110, 1092\u20131097 (2007).","journal-title":"Blood"},{"key":"BFng3380_CR58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bcmd.2012.06.004","volume":"49","author":"S Malak","year":"2012","unstructured":"Malak, S., Labopin, M., Saint-Martin, C., Bellanne-Chantelot, C. & Najman, A. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications. Blood Cells Mol. Dis. 49, 170\u2013176 (2012).","journal-title":"Blood Cells Mol. Dis."},{"key":"BFng3380_CR59","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1634\/stemcells.2008-0346","volume":"26","author":"P Mali","year":"2008","unstructured":"Mali, P. et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 26, 1998\u20132005 (2008).","journal-title":"Stem Cells"},{"key":"BFng3380_CR60","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1182\/blood.V88.4.1284.bloodjournal8841284","volume":"88","author":"N Debili","year":"1996","unstructured":"Debili, N. et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88, 1284\u20131296 (1996).","journal-title":"Blood"},{"key":"BFng3380_CR61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"BFng3380_CR62","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2008-01-134114","volume":"112","author":"I Plo","year":"2008","unstructured":"Plo, I. et al. JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood 112, 1402\u20131412 (2008).","journal-title":"Blood"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng.3380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3380","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:08:37Z","timestamp":1684429717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.3380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFng3380"],"URL":"https:\/\/doi.org\/10.1038\/ng.3380","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725726395.793510275","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,17]]},"assertion":[{"value":"3 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}